Precision Neurosciences has closed an impressive $102 million investment round as it races with Elon Musk's Neuralink and others to bring brain-computer interface (BCI) technology to the market. The ...
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback